COGNITIVE-BEHAVIORAL THERAPY FOR BENZODIAZEPINE DISCONTINUATION IN PANIC DISORDER PATIENTS

被引:0
作者
OTTO, MW
POLLACK, MH
MELTZERBRODY, S
ROSENBAUM, JF
机构
[1] MASSACHUSETTS GEN HOSP,CLIN PSYCHOPHARMACOL UNITS,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The discontinuation of benzodiazepine treatment in patients with panic disorder may be associated with emergent withdrawal and anxiety symptoms, relapse of panic, and the inability to complete benzodiazepine taper. Although some patients may respond to slow taper strategies or the use of pharmacologic adjuncts, many continue to experience significant difficulties during benzodiazepine discontinuation. This paper presents a cognitive-behavioral conceptualization of benzodiazepine discontinuation difficulties, emphasizing "fear of fear" cycles. From this perspective the discontinuation process is seen as exposing panic disorder patients to somatic sensations associated with panic at a time when there is both increased anxiety and concern about re-emergence or worsening of panic episodes. As a consequence, patients may re-enter a cycle of catastrophic interpretations of symptoms, increased vigilance and fear, and panic. Cognitive-behavioral interventions may ameliorate discontinuation-associated difficulties and prevent the return of the panic disorder. Preliminary data supporting the efficacy of these interventions are described.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [31] The current status of the treatment of panic disorder pharmacotherapy and cognitive-behavioral therapy
    Simon, NM
    Pollack, MH
    PSYCHIATRIC ANNALS, 2000, 30 (11) : 689 - 696
  • [32] Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation
    Tsao, JCI
    Mystkowski, JL
    Zucker, BG
    Craske, MG
    BEHAVIOUR RESEARCH AND THERAPY, 2005, 43 (07) : 959 - 970
  • [33] Effectiveness of cognitive-behavioral group therapy for panic disorder in a specialized unit
    Prats, Eva
    Dominguez, Elisabet
    Rosado, Silvia
    Pailhez, Guillem
    Bulbena, Antoni
    Fullana, Miguel A.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2014, 42 (04): : 176 - 184
  • [34] Adding cognitive-behavioral therapy to pharmacotherapy for panic disorder: Issues and strategies
    Otto, MW
    Powers, M
    Smits, JAJ
    CNS SPECTRUMS, 2005, 10 (09) : 32 - 39
  • [35] Client resistance predicts outcomes in cognitive-behavioral therapy for panic disorder
    Schwartz, Rachel A.
    Chambless, Dianne L.
    McCarthy, Kevin S.
    Milrod, Barbara
    Barber, Jacques P.
    PSYCHOTHERAPY RESEARCH, 2019, 29 (08) : 1020 - 1032
  • [36] Comorbid panic disorder and major depression: Implications for cognitive-behavioral therapy
    McLean, PD
    Woody, S
    Taylor, S
    Koch, WJ
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1998, 66 (02) : 240 - 247
  • [37] CONTROLLED DISCONTINUATION OF BENZODIAZEPINE TREATMENT FOR PATIENTS WITH PANIC DISORDER
    NOYES, R
    GARVEY, MJ
    COOK, B
    SUELZER, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (04) : 517 - 523
  • [38] Efficacy of cognitive-behavioral therapy for comorbid panic disorder with agoraphobia and generalized anxiety disorder
    Labrecque, Joane
    Marchand, Andr
    Dugas, Michel J.
    Letarte, Andree
    BEHAVIOR MODIFICATION, 2007, 31 (05) : 616 - 637
  • [39] COGNITIVE BIAS IN PANIC DISORDER PATIENTS AND CHANGES AFTER COGNITIVE-BEHAVIORAL TREATMENTS
    WESTLING, BE
    OST, LG
    BEHAVIOUR RESEARCH AND THERAPY, 1995, 33 (05) : 585 - 588
  • [40] Cognitive-behavioral therapy of patients with pure and comorbid panic disorder in a hospital setting -: a comparison of therapy response
    Rathgeb-Fuetsch, M
    Beer, U
    Urmann, I
    Pollmächer, T
    Schuld, A
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 270 - 270